Handelsbanken Fonder Ab Inogen Inc Transaction History

Handelsbanken Fonder Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$28.1 - $35.25 $192,906 - $241,991	-6,865 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$43.09 - $82.26 $12,927 - $24,678	300 Added 4.57%	6,865 $296,000
Q2 2021 Aug 03, 2021	BUY	$52.03 - $68.77 $20,812 - $27,508	400 Added 6.49%	6,565 $428,000
Q4 2020 Feb 11, 2021	BUY	$27.19 - $44.68 $167,626 - $275,452	6,165 New	6,165 $275,000
Q3 2020 Nov 13, 2020	SELL	$27.01 - $37.31 $166,516 - $230,016	-6,165 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$32.85 - $53.77 $202,520 - $331,492	6,165 New	6,165 $219,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.